This is considered a major achievement after numerous attempts and years of discussion. It should bring immediate and substantial benefits to the pharmaceutical industries for which Japan is one of the key markets. The expansion would also include active pharmaceutical ingredients and biological pharmaceuticals, including immunologicals and vaccines. Both Parties aim to complete all the formal procedures in the next few weeks, which would allow the entry into force of the new expanded product scope.
> Do not hesitate, we look forward to your feedback!
Write a comment on this news.